Beth Han, Christopher M Jones, Nora D Volkow, Emily B Einstein, Susan R B Weiss, Carlos Blanco, Wilson M Compton
{"title":"美国医学推荐和非医用大麻使用者中大麻消费方式的流行程度。","authors":"Beth Han, Christopher M Jones, Nora D Volkow, Emily B Einstein, Susan R B Weiss, Carlos Blanco, Wilson M Compton","doi":"10.1111/add.16741","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Some cannabis consumption methods (e.g. smoking, vaping, dabbing) are associated with more harms than others (e.g. sublingual, transdermal). We aimed to examine differences in prevalence of cannabis consumption methods by people with medically recommended-only vs. nonmedical-only cannabis use.</p><p><strong>Design and setting: </strong>Cross-sectional, US nationally representative data from the 2022 National Survey on Drug Use and Health (NSDUH).</p><p><strong>Participants: </strong>14 271 NSDUH participants aged ≥12 with past-year cannabis use.</p><p><strong>Measurements: </strong>NSDUH asked respondents with past-year cannabis use about their consumption methods [i.e. smoking, vaping, eating or drinking, dabbing (consuming a concentrated form with a dab rig/pen), oral/sublingual, transdermal or taking pills] and if healthcare professionals recommended any cannabis use. If 'no', respondents were classified as having 'nonmedical-only cannabis use'. If 'yes', they were asked if all cannabis use was recommended and, if so, they were classified as having 'medically recommended-only cannabis use'; otherwise, they were classified as having 'medical and nonmedical cannabis use'.</p><p><strong>Findings: </strong>Among people reporting cannabis use, 10.7% [95% confidence interval (CI) = 9.7%-11.7%] reported medically recommended-only use, and 83.0% (95% CI = 81.7%-84.3%) reported nonmedical-only use. Smoking was the predominant method for nonmedical-only use (79.2%, 95% CI = 77.7%-80.7%) and for medically recommended-only use (73.7%, 95% CI = 68.8%-78.2%). Vaping prevalence (45.6%, 95% CI = 40.9%-50.4%) and eating/drinking prevalence (45.7%, 95% CI = 40.7%-50.7%) were similar among people with medically recommended-only use. Vaping prevalence was 1.3 times higher [adjusted prevalence ratio (APR) = 1.3, 95% CI = 1.2-1.4] for medically recommended-only than for nonmedical-only use (38.3%, 95% CI = 32.7%-44.3%). Dabbing prevalence was 1.5 times higher (APR = 1.5, 95% CI = 1.3-1.7) for medically recommended-only than for nonmedical-only use [24.4% (95% CI = 20.5%-28.8%) vs 16.4% (95% CI = 15.3%-17.7%)]. Higher prevalence of oral/sublingual and transdermal methods was associated with medically recommended-only use.</p><p><strong>Conclusions: </strong>Among people with past-year medically recommended-only cannabis use in the US, three-fourths reported smoking cannabis and almost half reported vaping and eating/drinking cannabis. Cannabis vaping prevalence and dabbing prevalence were 1.3-1.5 times higher, respectively, among people with medically recommended-only use than people with nonmedical-only use.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States.\",\"authors\":\"Beth Han, Christopher M Jones, Nora D Volkow, Emily B Einstein, Susan R B Weiss, Carlos Blanco, Wilson M Compton\",\"doi\":\"10.1111/add.16741\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Some cannabis consumption methods (e.g. smoking, vaping, dabbing) are associated with more harms than others (e.g. sublingual, transdermal). We aimed to examine differences in prevalence of cannabis consumption methods by people with medically recommended-only vs. nonmedical-only cannabis use.</p><p><strong>Design and setting: </strong>Cross-sectional, US nationally representative data from the 2022 National Survey on Drug Use and Health (NSDUH).</p><p><strong>Participants: </strong>14 271 NSDUH participants aged ≥12 with past-year cannabis use.</p><p><strong>Measurements: </strong>NSDUH asked respondents with past-year cannabis use about their consumption methods [i.e. smoking, vaping, eating or drinking, dabbing (consuming a concentrated form with a dab rig/pen), oral/sublingual, transdermal or taking pills] and if healthcare professionals recommended any cannabis use. If 'no', respondents were classified as having 'nonmedical-only cannabis use'. If 'yes', they were asked if all cannabis use was recommended and, if so, they were classified as having 'medically recommended-only cannabis use'; otherwise, they were classified as having 'medical and nonmedical cannabis use'.</p><p><strong>Findings: </strong>Among people reporting cannabis use, 10.7% [95% confidence interval (CI) = 9.7%-11.7%] reported medically recommended-only use, and 83.0% (95% CI = 81.7%-84.3%) reported nonmedical-only use. Smoking was the predominant method for nonmedical-only use (79.2%, 95% CI = 77.7%-80.7%) and for medically recommended-only use (73.7%, 95% CI = 68.8%-78.2%). Vaping prevalence (45.6%, 95% CI = 40.9%-50.4%) and eating/drinking prevalence (45.7%, 95% CI = 40.7%-50.7%) were similar among people with medically recommended-only use. Vaping prevalence was 1.3 times higher [adjusted prevalence ratio (APR) = 1.3, 95% CI = 1.2-1.4] for medically recommended-only than for nonmedical-only use (38.3%, 95% CI = 32.7%-44.3%). Dabbing prevalence was 1.5 times higher (APR = 1.5, 95% CI = 1.3-1.7) for medically recommended-only than for nonmedical-only use [24.4% (95% CI = 20.5%-28.8%) vs 16.4% (95% CI = 15.3%-17.7%)]. Higher prevalence of oral/sublingual and transdermal methods was associated with medically recommended-only use.</p><p><strong>Conclusions: </strong>Among people with past-year medically recommended-only cannabis use in the US, three-fourths reported smoking cannabis and almost half reported vaping and eating/drinking cannabis. Cannabis vaping prevalence and dabbing prevalence were 1.3-1.5 times higher, respectively, among people with medically recommended-only use than people with nonmedical-only use.</p>\",\"PeriodicalId\":109,\"journal\":{\"name\":\"Addiction\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Addiction\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/add.16741\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/add.16741","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
目的：一些大麻消费方法（如吸烟、吸电子烟、轻吸）比其他方法（如舌下、透皮）的危害更大。我们的目的是研究仅使用医学推荐大麻和仅使用非医疗大麻的人群在大麻消费方式流行程度上的差异。设计和背景：来自2022年全国药物使用和健康调查（NSDUH）的美国全国代表性横断面数据。参与者：14 271名年龄≥12岁且过去使用过大麻的NSDUH参与者。测量：NSDUH向过去一年使用大麻的受访者询问了他们的消费方法[即吸烟、吸电子烟、吃或喝、轻吸（用dab rig/pen吸浓缩形式）、口服/舌下、透皮或服用药片]，以及医疗保健专业人员是否建议使用任何大麻。如果“否”，答复者被归类为“非仅用于医疗用途的大麻”。如果“是”，则询问他们是否建议使用所有大麻，如果是，则将他们归类为“医学建议仅使用大麻”；否则，他们被归类为“医用和非医用大麻用途”。研究结果：在报告大麻使用的人群中，10.7%[95%置信区间(CI) = 9.7%-11.7%]报告仅用于医学推荐用途，83.0% （95% CI = 81.7%-84.3%）报告仅用于非医学用途。吸烟是非医学使用的主要方法（79.2%,95% CI = 77.7%-80.7%）和医学推荐使用的主要方法（73.7%,95% CI = 68.8%-78.2%）。在仅使用医学推荐的人群中，电子烟患病率（45.6%,95% CI = 40.9%-50.4%）和饮食患病率（45.7%,95% CI = 40.7%-50.7%）相似。医学推荐使用的电子烟患病率是非医学推荐使用的电子烟患病率（38.3%,95% CI = 32.7%-44.3%）的1.3倍[调整患病率比(APR) = 1.3, 95% CI = 1.2-1.4]。仅医学推荐使用的涂抹普及率是非医学推荐使用的1.5倍（APR = 1.5, 95% CI = 1.3-1.7） [24.4% (95% CI = 20.5%-28.8%) vs 16.4% (95% CI = 15.3%-17.7%)]。口腔/舌下和透皮方法的较高流行率与医学推荐的仅使用相关。结论：在美国过去一年中仅使用医学推荐大麻的人中，四分之三的人报告吸食大麻，近一半的人报告吸食和食用/饮用大麻。仅在医学上推荐使用大麻的人群中，吸食大麻的流行率和吸食大麻的流行率分别比仅在非医学上使用大麻的人群高1.3-1.5倍。
Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States.
Aims: Some cannabis consumption methods (e.g. smoking, vaping, dabbing) are associated with more harms than others (e.g. sublingual, transdermal). We aimed to examine differences in prevalence of cannabis consumption methods by people with medically recommended-only vs. nonmedical-only cannabis use.
Design and setting: Cross-sectional, US nationally representative data from the 2022 National Survey on Drug Use and Health (NSDUH).
Measurements: NSDUH asked respondents with past-year cannabis use about their consumption methods [i.e. smoking, vaping, eating or drinking, dabbing (consuming a concentrated form with a dab rig/pen), oral/sublingual, transdermal or taking pills] and if healthcare professionals recommended any cannabis use. If 'no', respondents were classified as having 'nonmedical-only cannabis use'. If 'yes', they were asked if all cannabis use was recommended and, if so, they were classified as having 'medically recommended-only cannabis use'; otherwise, they were classified as having 'medical and nonmedical cannabis use'.
Findings: Among people reporting cannabis use, 10.7% [95% confidence interval (CI) = 9.7%-11.7%] reported medically recommended-only use, and 83.0% (95% CI = 81.7%-84.3%) reported nonmedical-only use. Smoking was the predominant method for nonmedical-only use (79.2%, 95% CI = 77.7%-80.7%) and for medically recommended-only use (73.7%, 95% CI = 68.8%-78.2%). Vaping prevalence (45.6%, 95% CI = 40.9%-50.4%) and eating/drinking prevalence (45.7%, 95% CI = 40.7%-50.7%) were similar among people with medically recommended-only use. Vaping prevalence was 1.3 times higher [adjusted prevalence ratio (APR) = 1.3, 95% CI = 1.2-1.4] for medically recommended-only than for nonmedical-only use (38.3%, 95% CI = 32.7%-44.3%). Dabbing prevalence was 1.5 times higher (APR = 1.5, 95% CI = 1.3-1.7) for medically recommended-only than for nonmedical-only use [24.4% (95% CI = 20.5%-28.8%) vs 16.4% (95% CI = 15.3%-17.7%)]. Higher prevalence of oral/sublingual and transdermal methods was associated with medically recommended-only use.
Conclusions: Among people with past-year medically recommended-only cannabis use in the US, three-fourths reported smoking cannabis and almost half reported vaping and eating/drinking cannabis. Cannabis vaping prevalence and dabbing prevalence were 1.3-1.5 times higher, respectively, among people with medically recommended-only use than people with nonmedical-only use.
期刊介绍：
Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines.
Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries.
Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
